Market Movers Archives | Page 313 of 872 | Smartkarma

The Cooper Companies, Inc. (COO)

81.27 USD -3.08 (-3.65%) Volume: 2.06M

The Cooper Companies, Inc.’s stock price stands at 81.27 USD, experiencing a 3.65% decrease this trading session with a trading volume of 2.06M. The stock has seen a year-to-date percentage change of -11.60%, reflecting its performance in the market.

Latest developments on The Cooper Companies, Inc.

Today, the stock price of Cooper Companies (NASDAQ:COO) experienced a significant surge as Rocket Companies announced its acquisition of Mr. Cooper Group in a massive $9.4 billion all-stock deal. This acquisition marks a major milestone in the real estate industry, with Rocket Companies, the nation’s largest lender, joining forces with America’s largest servicer, Mr. Cooper. The news of this bombshell deal has sent shockwaves through the market, leading to a surge in Mr. Cooper’s stock price. Analysts are closely monitoring the situation, setting a price target of $110.25 for Cooper Companies (NASDAQ:COO) as it navigates this new chapter in its return trends.

A look at The Cooper Companies, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Cooper Cos /, a company that develops specialty healthcare products, is showing a mixed outlook based on the Smartkarma Smart Scores. While the company scores high on factors like growth and momentum, it falls short in areas like dividend and resilience. This suggests that Cooper Cos / may have potential for future expansion and market success, but investors should also consider the company’s ability to withstand economic challenges.

Overall, Cooper Cos / receives a moderate rating from the Smartkarma Smart Scores, with strengths in growth and momentum. However, the company’s lower scores in areas like dividend and resilience indicate potential risks that investors should be aware of. As Cooper Cos / continues to develop and market specialty healthcare products, keeping an eye on these factors will be crucial for assessing its long-term performance in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

The Interpublic Group of Companies, Inc. (IPG)

26.12 USD -1.04 (-3.83%) Volume: 6.2M

The Interpublic Group of Companies, Inc.’s stock price is currently at 26.12 USD, experiencing a decrease of -3.83% this trading session with a trading volume of 6.2M. Its year-to-date performance shows a decline of -6.78%, reflecting its market volatility.

Latest developments on The Interpublic Group of Companies, Inc.

Interpublic Group of Companies Inc. (IPG) stock saw a positive movement today after receiving early approval to proceed with a merger with Omnicom. This news comes after recent concerns about the stock underperforming the S&P 500. Despite this, Interpublic Group of Companies stock outperformed competitors on a strong trading day. Analysts are optimistic about the company’s future, with Wall Street’s most accurate analysts weighing in on tech and telecom stocks, including IPG, which offer over 3% dividend yields. These factors have contributed to the upward trend in Interpublic Group of Companies stock price today.

The Interpublic Group of Companies, Inc. on Smartkarma

Analysts at Baptista Research have recently covered Interpublic Group Of Companies on Smartkarma, highlighting the challenges the company faces in managing agency restructuring and brand overhaul. The report, titled “Interpublic Group of Companies: Dealing With Challenges of Managing Agency Restructuring & Brand Overhaul! – Major Drivers,” discusses the company’s stable yet complex performance during the Third Quarter of 2024. Despite ongoing market challenges, Interpublic Group reported flat organic growth year-over-year and a 2.9% decrease in net revenue. The company’s revenue before billable expenses remained unchanged compared to the previous year.

A look at The Interpublic Group of Companies, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, the long-term outlook for Interpublic Group Of Companies appears to be positive overall. The company received high scores in Dividend and Momentum, indicating that it is performing well in terms of dividend payments and market momentum. However, its scores in Value and Growth are average, suggesting that there may be room for improvement in these areas. Additionally, the company scored low in Resilience, which could indicate potential vulnerabilities in the face of economic challenges.

The Interpublic Group of Companies, Inc. is a global organization that operates in various sectors of advertising and marketing services. With a diverse range of services including healthcare communications, public relations, and sports marketing, the company has established itself as a key player in the industry. While it has strengths in dividend payments and market momentum, there may be opportunities for growth and improvement in other areas such as value and resilience.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Pfizer Inc. (PFE)

24.54 USD -0.80 (-3.16%) Volume: 54.28M

Pfizer Inc.’s stock price currently stands at 24.54 USD, experiencing a decrease of -3.16% this trading session with a trading volume of 54.28M. With a Year-To-Date (YTD) percentage change of -7.50%, Pfizer’s stock performance continues to be a key focus for investors.

Latest developments on Pfizer Inc.

Pfizer’s stock price movements today have been influenced by a series of key events, including the European Commission’s approval of Pfizer’s RSV vaccine for adults at increased risk of disease. The company’s collaboration with Flagship Pioneering to develop AI-driven autoimmune treatments has also garnered attention. Despite facing challenges such as losing an appeal to patent a cancer drug dosage, Pfizer remains a top contender in the healthcare sector. Analysts believe Pfizer is undervalued, making it a potential buy for investors. With its strong financial performance and strategic developments, Pfizer continues to be a standout choice among blue-chip stocks, even amid recent fluctuations in the market.

A look at Pfizer Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Pfizer has a strong outlook for its dividend and value, scoring a 5 and 4 respectively. This indicates that the company is performing well in terms of returning profits to shareholders and being undervalued in the market. However, its growth and resilience scores are lower at 2, suggesting that there may be some challenges in these areas. Despite this, Pfizer’s momentum score of 4 shows that the company is currently experiencing positive market trends.

Pfizer Inc. is a pharmaceutical company that offers a range of medical products in various therapeutic areas. With a high dividend score and solid value score, the company seems to be in a good position to provide returns to its investors. While its growth and resilience scores are not as strong, Pfizer’s momentum score indicates that it is currently on a positive trajectory. Overall, Pfizer serves customers globally and continues to be a key player in the pharmaceutical industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Moderna, Inc. (MRNA)

27.16 USD -1.19 (-4.20%) Volume: 11.62M

Moderna, Inc.’s stock price is currently trading at 27.16 USD, experiencing a drop of -4.20% this trading session with a trading volume of 11.62M, reflecting a YTD decrease of -34.68%.

Latest developments on Moderna, Inc.

Moderna stock price took a hit today as the FDA’s vaccine chief resigned, pointing to misinformation from RFK Jr. This comes after Moderna faced legal scrutiny, leading to a 5-year low in stock value. With a 53% estimated effectiveness against COVID hospitalization, Moderna’s regulatory risks mounted as the FDA shake-up rocked the company. The resignation of FDA officials has caused Moderna stock to plummet, affecting investor sentiment and leading to a significant -8% dip over the last month. As Moderna faces a legal spotlight, its stock continues to slide amid market challenges and concerns about vaccine regulations.

Moderna, Inc. on Smartkarma

Analysts at Baptista Research have been closely following Moderna Inc.’s financial performance and strategic positioning. In a recent report titled “Moderna Inc.: Is Its mRNA Platform Fueling A Multi-Billion-Dollar Pipeline Beyond COVID?”, they discussed the company’s opportunities and challenges. Despite a 53% decrease in total revenue for 2024 compared to the previous year, Moderna recorded $3.2 billion in revenue. The company also reported a net loss of $3.6 billion, showing a slight improvement from the previous year.

Another report by Baptista Research, titled “Moderna Inc.: Expanding Global Presence For Unmatched Impact! – Major Drivers,” highlighted the company’s financial results for the third quarter of 2024. With $1.9 billion in revenue, a net income of $13 million, and $9.2 billion in cash and investments, Moderna demonstrated a strong financial position. This robust liquidity provides the company with a solid foundation to support its ongoing and future initiatives, as analyzed by the independent analysts at Baptista Research on Smartkarma.

A look at Moderna, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Moderna, Inc. is a biotechnology company that specializes in messenger RNA therapeutics and vaccines. With strong scores in Value, Resilience, and Momentum, the company shows promising long-term potential. Its focus on developing mRNA medicines for various diseases positions it well for growth and innovation in the biotech industry.

Although Moderna scores lower in Dividend and Growth, its overall outlook remains positive. The company’s emphasis on research and development, particularly in infectious, immuno-oncology, and cardiovascular diseases, showcases its commitment to advancing healthcare solutions. Investors may find Moderna’s strong scores in key areas reassuring for its long-term prospects in the biotechnology sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Waters Corporation (WAT)

356.00 USD -12.57 (-3.41%) Volume: 0.56M

Waters Corporation’s stock price stands at 356.00 USD, witnessing a drop of -3.41% this trading session with a trading volume of 0.56M. Despite the current session’s setback, the stock’s Year-To-Date (YTD) performance shows a relatively minor decline of -4.04%, reflecting the firm’s resilience in the stock market.

Latest developments on Waters Corporation

Waters stock price movement today may be influenced by a variety of events leading up to this point. From aggressive sea lion attacks in Southern California waters to the discovery of 755 seals in Rhode Island waters, environmental concerns have been at the forefront. Political controversies, such as Melania Trump’s citizenship sparking debate after Maxine Waters’ comments, have also made waves. Additionally, advancements in technology, like CoreWeave’s IPO testing the waters and the expansion of Waters’ Bio HPLC product line, have impacted the market. Tragic incidents, such as the recovery of a missing LA firefighter’s body from Long Beach waters, have also played a role in shaping the current stock landscape. With various factors at play, investors are navigating uncertain waters as they monitor Waters’ stock performance.

A look at Waters Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores for Waters, the company seems to have a mixed long-term outlook. While it scores well in terms of Growth and Momentum, indicating potential for future expansion and strong market performance, it falls short in Value, Dividend, and Resilience. This suggests that Waters may face challenges in terms of its financial stability and ability to provide consistent returns to shareholders. Despite its strengths in certain areas, investors may want to carefully consider the overall balance of factors before making investment decisions related to Waters.

Waters Corporation, a provider of high-performance liquid chromatography products and services, operates in various industries worldwide, including pharmaceuticals, chemicals, and environmental testing. The company also offers thermal analysis, rheometry, calorimetry instruments, and related software products. With a Smartkarma Smart Score breakdown revealing strengths in Growth and Momentum but weaknesses in Value, Dividend, and Resilience, Waters faces a complex long-term outlook. Investors should conduct thorough research and analysis to assess the potential risks and rewards associated with investing in Waters.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Chipotle Mexican Grill, Inc. (CMG)

51.67 USD +1.46 (+2.91%) Volume: 12.13M

Chipotle Mexican Grill, Inc.’s stock price stands at 51.67 USD, marking a positive shift of +2.91% in this trading session with a robust trading volume of 12.13M. However, it has seen a year-to-date decrease of -14.31%, reflecting its volatile performance in the market.

Latest developments on Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill has been making headlines recently with their latest promotion, giving away over $1 million worth of free burritos through their Burrito Vault game. This move comes amidst rumors of the chain closing all its locations, which have been debunked. Despite this, Chipotle’s stock has been performing well, outperforming competitors on a strong trading day. The company’s strategic growth plans include opening new locations in various counties and providing free meals for winners of esports competitions. With their stock price movements closely watched by investors, Chipotle continues to attract attention with their innovative marketing strategies and expansion efforts.

Chipotle Mexican Grill, Inc. on Smartkarma

Analysts at Baptista Research have provided bullish coverage on Chipotle Mexican Grill, highlighting both the company’s robust growth and operational challenges. In their research reports, they noted a 13% increase in sales for the fourth quarter of 2024, reaching $2.8 billion, driven by a 5.4% increase in comparable sales and a 4% increase in transaction growth. For the full fiscal year 2024, sales grew by 15% to $11.3 billion, with a 7.4% increase in comparable sales, including over 5% transaction growth.

Further analysis by Baptista Research delves into the factors impacting Chipotle Mexican Grill‘s performance in 2025 and beyond. The company reported a 13% increase in sales for the third quarter of 2024, reaching $2.8 billion, with a 6% comparable sales growth. Transaction growth also played a significant role, contributing over 3% and indicating strong customer engagement. Despite facing challenges, the analysts remain bullish on Chipotle Mexican Grill‘s future prospects.

A look at Chipotle Mexican Grill, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Chipotle Mexican Grill has a mixed outlook based on the Smartkarma Smart Scores. While the company scores well in terms of growth potential, resilience, and momentum, it falls short in terms of value and dividend offerings. With a strong focus on expanding its presence and adapting to changing consumer preferences, Chipotle Mexican Grill is positioned for growth in the long term.

Despite facing some challenges, Chipotle Mexican Grill remains a resilient player in the quick-serve restaurant industry. The company’s ability to adapt to changing market conditions and maintain a steady momentum bodes well for its long-term prospects. While there may be room for improvement in terms of value and dividend offerings, Chipotle Mexican Grill‘s strong performance in growth, resilience, and momentum factors signals a positive outlook for the company.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

CrowdStrike Holdings, Inc. (CRWD)

362.38 USD +9.80 (+2.78%) Volume: 2.67M

CrowdStrike Holdings, Inc.’s stock price is currently at a robust 362.38 USD, showcasing a positive trading session with a 2.78% increase and an impressive trading volume of 2.67M. With a year-to-date percentage change of +5.91%, CRWD’s stock performance exemplifies solid growth and investment potential.

Latest developments on CrowdStrike Holdings, Inc.

Today, Crowdstrike Holdings’ stock price movements have been influenced by a series of key events. Stephens initiated coverage on the company with an Overweight rating and a price target of $450, highlighting the growth potential. Jim Cramer expressed optimism about Crowdstrike, believing the stock is ready to rebound after a recent outage. Additionally, Nomura Asset Management Co. Ltd. increased their stake in Crowdstrike, while J.P. Morgan provided bullish support amid accelerated ARR. Despite Jefferies lowering the price target to $410 from $425, the tech CEO continues to tout Crowdstrike’s catalysts and strengths, further shaping the big picture for the company.

CrowdStrike Holdings, Inc. on Smartkarma

Analysts at Baptista Research have been closely following Crowdstrike Holdings and have published insightful reports on the company’s performance. In their report titled “Crowdstrike Holdings: The Falcon Flex Program & Key Developments That Are Strengthening Its Market Position!”, they highlight the company’s resilience and strategic growth in Q4 and Fiscal Year 2025. With a notable Q4 net new Annual Recurring Revenue (ARR) of $224 million, CrowdStrike ended FY 2025 with $4.24 billion in ARR, exceeding expectations and demonstrating effective management.

In another report by Baptista Research titled “CrowdStrike Holdings: How Are They Executing Expansion Beyond Endpoint Security? – Major Drivers”, analysts discuss the company’s fiscal third-quarter results for 2025. Despite facing some challenges, CrowdStrike achieved key milestones with annual recurring revenue (ARR) surpassing $4 billion and total revenue exceeding $1 billion for the first time. The 31% year-over-year growth in subscription revenue reflects the strong demand for CrowdStrike’s cybersecurity offerings in the evolving market driven by AI technologies.

A look at CrowdStrike Holdings, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, Crowdstrike Holdings has a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company is positioned well for future success. The company’s focus on providing cybersecurity products and services to prevent breaches has led to strong growth prospects and a resilient business model. Additionally, its momentum in the market indicates a positive trend for the company’s performance in the coming years.

Crowdstrike Holdings’ Smart Scores reflect a company with solid fundamentals and a promising future. While the Value and Dividend scores may be lower, the high scores in Growth, Resilience, and Momentum show that the company is well-positioned to capitalize on its cybersecurity offerings. With a global customer base and a range of security solutions, Crowdstrike Holdings is poised to continue its success in the cybersecurity industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Southwest Airlines Co. (LUV)

31.59 USD -1.99 (-5.93%) Volume: 17.82M

Southwest Airlines Co.’s stock price currently stands at 31.59 USD, experiencing a significant decrease of -5.93% in this trading session with a substantial trading volume of 17.82M. The stock’s performance has been struggling year-to-date, reflecting a -6.04% decline, indicating a challenging period for the company’s investors.

Latest developments on Southwest Airlines Co.

Southwest Airlines Co (LUV) has been making headlines with a series of strategic moves and stock price fluctuations. Recently, the airline saw a stock upgrade amid strategic changes, but then faced a drop after a downgrade by Jefferies. Despite this, Southwest launched new group booking tools and added flights for the 2025 holiday season. The airline also expanded its routes to various destinations, including Nashville, Albany, and San Diego. Alongside competitors like Delta and American Airlines, Southwest has been facing stock downgrades, but continues to make changes to improve the travel experience for customers. Delta Air Lines even made a surprising offer to Southwest customers, showcasing the competitive landscape in the airline industry. With all these developments, investors are wondering if Southwest Airlines Co is the best airline stock to buy now.

Southwest Airlines Co. on Smartkarma

Analysts at Baptista Research have been closely monitoring Southwest Airlines Co on Smartkarma, an independent investment research network. In their recent reports, they delved into the airline’s fleet optimization strategy to maximize economic benefits. Southwest Airlines reported its fourth-quarter and full-year 2024 financial performance, showcasing strategic developments and operational adjustments as part of its ongoing transformation plan “Southwest.Even Better”. The analysts have a bullish sentiment towards the company’s efforts to improve efficiency, reduce costs, and enhance customer experience.

Furthermore, Baptista Research also analyzed Southwest Airlines Co‘s latest fleet monetization strategy in another report. The airline presented its third-quarter 2024 earnings, highlighting updates on operational performance, revenue outcomes, and strategic initiatives aligned with the Southwest Even Better transformational plan. With CEO Bob Jordan leading the management team, the focus is on enhancing shareholder value and optimizing customer service. Baptista Research aims to evaluate various factors influencing the company’s price and conduct an independent valuation using a Discounted Cash Flow methodology, indicating a positive outlook on Southwest Airlines Co.

A look at Southwest Airlines Co. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Southwest Airlines Co. has been given a high score in Momentum by Smartkarma Smart Scores, indicating a positive outlook for the company’s future growth and performance. With a strong focus on short-haul, high-frequency flights within the United States, Southwest Airlines Co. is well-positioned to capitalize on its resilient business model and continue to attract investors.

Additionally, Southwest Airlines Co. has received favorable scores in Dividend and Resilience, further solidifying its standing in the market. While the Value and Growth scores are not as high, the overall outlook for Southwest Airlines Co. remains positive, making it a company to watch for potential long-term investment opportunities.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Axon Enterprise, Inc. (AXON)

541.20 USD +15.25 (+2.90%) Volume: 0.51M

Axon Enterprise, Inc.’s stock price is currently standing strong at 541.20 USD, marking a positive trading session with a 2.90% increase. Despite a year-to-date decrease of 8.94%, the stock maintains a robust trading volume of 0.51M, making AXON a noteworthy player in the stock market.

Latest developments on Axon Enterprise, Inc.

Axon Enterprise (AXON) has been making headlines recently with various events impacting its stock price. From outperforming competitors on a strong trading day to setting a new 1-year low, the company has been attracting attention. Additionally, news of insider selling worth US$81m has raised concerns about potential weaknesses. Despite this, analysts are still optimistic about Axon’s future, citing factors like EPS growth. Brokers are even suggesting investing in Axon, making it an interesting bet for investors. With lobbying updates and insights from CEOs of leading companies like Gensler and Betterment, Axon Enterprise continues to be a topic of interest in the market.

A look at Axon Enterprise, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Axon Enterprise has a positive long-term outlook. With a high score in Growth, the company is expected to experience significant expansion in the future. Additionally, Axon Enterprise scored well in Resilience and Momentum, indicating its ability to withstand challenges and maintain a strong performance trend. Despite lower scores in Value and Dividend, the overall outlook for Axon Enterprise remains optimistic.

Axon Enterprise, Inc. is a public safety technology company that provides solutions for law enforcement, military, and self-defense. With a global customer base, the company is positioned to capitalize on its strong Growth, Resilience, and Momentum scores. Although there may be room for improvement in terms of Value and Dividend, Axon Enterprise’s overall outlook suggests a promising future in the public safety technology sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Johnson & Johnson (JNJ)

153.25 USD -12.59 (-7.59%) Volume: 23.29M

Johnson & Johnson’s stock price currently stands at 153.25 USD, down by 7.59% this trading session with a trading volume of 23.29M. Despite this recent dip, the stock still boasts a positive year-to-date (YTD) percentage change of +5.97%, showcasing its resilience in the market.

Latest developments on Johnson & Johnson

Recent events have caused significant fluctuations in Johnson & Johnson‘s stock price. A US judge rejected the company’s $10 billion settlement related to baby powder lawsuits, leading to a $1.64 billion penalty in an HIV drug marketing case. This setback, along with failed attempts at talc settlement plans and a rejected bankruptcy strategy, has resulted in a 5% stock decline. Despite these challenges, Johnson & Johnson remains a top pick among healthcare stocks, with ongoing efforts to finalize acquisitions and maintain earnings surprises. The company’s legal battles and financial uncertainties have led to a hold rating, but it continues to invest in US manufacturing facilities and vows to keep fighting talc cases in court.

A look at Johnson & Johnson Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Johnson & Johnson, a company known for manufacturing health care products, seems to have a positive long-term outlook based on its Smartkarma Smart Scores. The company scores high in Dividend and Momentum, indicating strong performance in these areas. With a focus on providing essential services in the consumer, pharmaceutical, and medical devices markets, Johnson & Johnson‘s resilience score could be higher, but its overall outlook remains promising.

Despite facing some challenges in resilience, Johnson & Johnson‘s strong performance in Dividend and Momentum bodes well for its future growth. The company’s ability to consistently provide dividends to investors and maintain positive momentum in the market reflects its stability and potential for long-term success. With a diverse range of products sold globally, including pharmaceuticals and diagnostic equipment, Johnson & Johnson continues to position itself as a key player in the health care industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma